[CAS NO. 32462-30-9] Oxfenicine
PRODUCTS SPECIFICATIONS [32462-30-9]
DESCRIPTION [32462-30-9]
Overview
| MDL | MFCD00065932 |
|---|---|
| Molecular Weight | 167.16 |
| Molecular Formula | C8H9NO3 |
| SMILES | O=C(O)[C@@H](N)C1=CC=C(O)C=C1 |
Summary
IC50 & Target
carnitine palmitoyltransferase-1 [1]
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
H 2 O : 4.55 mg/mL ( 27.22 mM ; Need ultrasonic)
DMSO : 1 mg/mL ( 5.98 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 5.9823 mL | 29.9115 mL | 59.8229 mL |
| 5 mM | 1.1965 mL | 5.9823 mL | 11.9646 mL |
| 10 mM | 0.5982 mL | 2.9911 mL | 5.9823 mL |
-
1.
Add each solvent one by one: PBS
Solubility: 2 mg/mL (11.96 mM); Clear solution; Need ultrasonic and warming and heat to 60°C
References
- [1] Stephens TW, et, al. Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine. Biochem J. 1985 Apr 15;227(2):651-60.
- [2] Greaves P, et, al. Cardiac hypertrophy in the dog and rat induced by oxfenicine, an agent which modifies muscle metabolism. Arch Toxicol Suppl. 1984;7:488-93.
Synonyms